Preclinical data suggest that Moderna’s mpox vaccine could be superior to other alternatives currently approved, according to new research published Wednesday.
Scientists
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday.
A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising immune responses and improved recurrence-free survival in high-risk
Generalised myasthenia gravis is a rare condition – but UCB’s Rystiggo enters a competitive market. Source: Shutterstock / Giovanni Cancemi. Belgian biopharmaceutical company UCB has